Standout Papers

Update on Key Emerging Challeng... 1990 2026 2002 2014 2.6k
  1. Update on Key Emerging Challenges in Cystic Fibrosis (2014)
    Mark T. Jennings, Kristin A. Riekert et al. Medical Principles and Practice
  2. Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR (2015)
    Claire Wainwright, J.S. Elborn et al. New England Journal of Medicine
  3. Multiattribute and Single-Attribute Utility Functions for the Health Utilities Index Mark 3 System (2002)
    David Feeny, William Furlong et al. Medical Care
  4. Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and Necrosis (1990)
    Harlan F. Weisman, Michelle K. Leppo et al. Science
  5. Multi-Attribute Health Status Classification Systems (1995)
    David Feeny, William Furlong et al. PharmacoEconomics
  6. Chronic Illness, Disability, and Mental and Social Well-Being: Findings of the Ontario Child Health Study (1987)
    David Cadman, Michael Boyle et al. PEDIATRICS
  7. Child abuse and mental disorders in Canada (2014)
    Tracie O. Afifi, Harriet L. MacMillan et al. Canadian Medical Association Journal
  8. A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial (2014)
    Michael Boyle, Scott C. Bell et al. The Lancet Respiratory Medicine

Immediate Impact

8 by Nobel laureates 8 from Science/Nature 73 standout
Sub-graph 1 of 21

Citing Papers

Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Charge-assisted stabilization of lipid nanoparticles enables inhaled mRNA delivery for mucosal vaccination
2024 Standout

Works of Michael Boyle being referenced

Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation
2017
Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier
2014

Author Peers

Author Last Decade Papers Cites
Michael Boyle 3843 6326 2056 2250 208 18.6k
Sue Duval 3121 3377 1816 1183 170 28.5k
Gerta Rücker 2346 2210 1136 1470 179 21.9k
Malcolm R. Sears 2532 6886 1692 3473 291 23.7k
Peter Herbison 2751 5063 1228 850 392 21.7k
Karina W. Davidson 3417 3528 1602 1164 400 29.1k
Alex R. Kemper 1373 2765 1922 1088 234 16.1k
Michael Silverstein 2021 2367 2194 790 188 16.1k
Howard Cabral 2617 3708 3763 737 427 17.2k
Joseph T. F. Lau 4487 2336 1389 1540 590 27.6k
Thomas Perneger 1667 2428 918 848 346 24.1k

All Works

Loading papers...

Rankless by CCL
2026